ID
45535
Beskrivning
Principal Investigator: Kendall Van Keuren-Jensen, PhD, The Translational Genomics Research Institute (TGen), Phoenix, AZ, USA MeSH: Alzheimer Disease,Parkinson Disease https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000727 We profiled the miRNA contents from cerebrospinal fluid and serum (using next generation sequencing) from postmortem patients diagnosed with Alzheimer's or Parkinson's disease, and neurologically normal controls. All biofluids were cell-free and patient matched, there was one cerebrospinal fluid and one serum sample from each of 70 patients with Alzheimer's disease, 67 patients with Parkinson's disease and 78 age-similar controls. We correlated the miRNA changes with measurements of neuropathology such as plaques, tangles and Lewy bodies.
Länk
Nyckelord
Versioner (1)
- 2022-12-28 2022-12-28 - Chiara Middel
Rättsinnehavare
Kendall Van Keuren-Jensen, PhD, The Translational Genomics Research Institute (TGen), Phoenix, AZ, USA
Uppladdad den
28 december 2022
DOI
För en begäran logga in.
Licens
Creative Commons BY 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
dbGaP phs000727 miRNA profiles in serum and CSF of Parkinson's and Alzheimer's patients
Subject - Sample Mapping
- StudyEvent: SEV1
- Eligibility Criteria
- Subject - Consent - Affection Status Information
- Subject - Sample Mapping
- The dataset provides information about disease duration, presence of APOE alleles, time interval between death and tissue harvest, location and extend of plaque and tangle formation, degree of Substantia Nigra depigmentation and status of Lewy body formation observed, Braak/NIA-Reagan scores and general sociodemographic information.
- Sample Attribute Information
Similar models
Subject - Sample Mapping
- StudyEvent: SEV1
- Eligibility Criteria
- Subject - Consent - Affection Status Information
- Subject - Sample Mapping
- The dataset provides information about disease duration, presence of APOE alleles, time interval between death and tissue harvest, location and extend of plaque and tangle formation, degree of Substantia Nigra depigmentation and status of Lewy body formation observed, Braak/NIA-Reagan scores and general sociodemographic information.
- Sample Attribute Information
C0449416 (UMLS CUI [1,2])
C2347026 (UMLS CUI [1,3])
C3847505 (UMLS CUI [1,2])
C0449416 (UMLS CUI [1,3])